(Health Korea News / Yoo Ji-in) Yonsei University’s Graduate School of Convergence Health and Medical Sciences is newly opening after receiving approval from the Ministry of Education last month.
The Graduate School of Convergence Health and Medical Science plans to cultivate talent who will lead the future health and medical industry by converging various disciplines related to health and medical care and lead a new health and medical paradigm through cutting-edge research and knowledge creation.
The Graduate School of Convergence Health and Medical Sciences consists of ▲Department of Biohealth Industry, including Biohealth Policy Analysis Major and Biohealth Industry Management Major, ▲Department of Convergence Health and Medical Science, including Precision Medicine Genome Epidemiology Major and Biohealth Data Science Major, and ▲Biomedical Engineering Major, Regenerative Medicine Major, and Aging Science Major. The Department of Bio-Health Engineering consists of a total of 7 majors and 3 departments.
The Biohealth Policy Analysis major in the Department of Biohealth Industry studies overall health care policies, including biohealth, policy analysis, and evaluation methodology. The Biohealth Industry Management major covers medical industry startups, management, marketing, financial accounting, and organizational theory, etc. Learn in a variety of ways.
The Department of Convergence Health and Medical Science majors in Precision Medical Genomic Epidemiology, which specializes in precision medicine such as genome, proteome, and transcriptome concepts as well as disease risk intervention methods, and the Biohealth Data Science Major, which deals with big data analysis, statistical programming, and causality inference methods between data. It consists of
The Department of Biohealth Engineering has a biomedical engineering major that studies various biomedical engineering fields such as metals, ceramics, and polymer biomaterials, as well as preclinical and clinical trials of medical devices, a regenerative medicine major that studies advanced regenerative medical technologies such as stem cell science and nanobio technology, and aging. It is divided into specialized aging science majors.
The annual number of students enrolled is 32, 18 in the master’s program and 14 in the doctoral program, and the first class of students will enroll on March 1, 2025. Admission notices will be announced in October, and new students will be selected through interviews after November.
Lee Sang-gyu, Chairman of the Establishment Preparation Committee, said, “Convergence that creates synergy by combining medicine with various disciplines such as engineering, public policy, management, and data science is becoming an academic trend.” He added, “We will produce convergence talents in the healthcare field who have both theory and practice.” He said.
Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited
Source: www.hkn24.com
